Evidence map›Paper›PMID 42303805›Full record

ArticleJournal of robotic surgery2026

Urological telesurgery after the first randomised trial: a scoping review and public implementation visibility audit.

Rafał Bogdan Drobot, Jędrzej Jakub Skorupka, Artur Andrzej Antoniewicz

Abstract readScoping Review
In one paragraph

Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rafał Bogdan DrobotUrology Department, Institute of Medical Sciences, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, Bursztynowa 2, Warsaw, 04-479, Poland. r.drobot@uksw.edu.pl.ORCID http://orcid.org/0000-0003-2627-298X
Jędrzej Jakub SkorupkaDepartment of Urology and Urological Oncology, Multidisciplinary Hospital in Warsaw-Miedzylesie, Bursztynowa 2, Warsaw, 04-479, Poland.
Artur Andrzej AntoniewiczUrology Department, Institute of Medical Sciences, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, Bursztynowa 2, Warsaw, 04-479, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urological telesurgery has moved from isolated demonstrations to multicentre and randomised evaluation. We mapped the public evidence after the first randomised trial and assessed whether implementation-critical details are visible in reports that readers can independently appraise. We performed a PRISMA-ScR evidence map and public-record audit of peer-reviewed human urological telesurgery reports available to 26 April 2026. Eligible reports described direct remote operative control across physically separate sites. Because brief abstracts and public summaries cannot reliably accommodate full implementation detail, full-text or publicly available full-text records were prespecified as the primary visibility analysis and short public records were analysed separately. Two reviewers independently coded IDEAL stage and predefined implementation-visibility items, with third-reviewer adjudication. Item-level frequencies were reported; no report-level score, total or ranking was calculated. Sixteen reports were included: eight full-text or public full-text records and eight short public records. Six reports were stage 1, seven stage 2a, two stage 2b and one stage 3; no stage 4 surveillance report was identified. In the primary full-text/public full-text analysis, network architecture and clinical outcomes were visible in 8/8 records; distance or site separation and quantitative latency in 7/8 each; advanced network metrics, backup or failover, on-site rescue or takeover planning and technical adverse events in 6/8 each; ethics or governance in 5/8; registration or protocol identifiers in 2/8; and cybersecurity or data-protection measures in 1/8. Short public records showed lower visibility for several implementation items, particularly backup or failover (1/8), governance (2/8), registration (1/8) and cybersecurity (0/8). Agreement was 168/176 (95.5%; Cohen kappa 0.91) for binary visibility items and 15/16 (93.8%; linearly weighted kappa 0.93) for IDEAL stage; nine extraction calls were adjudicated. A programme-cluster sensitivity analysis collapsed the 16 reports into seven visible programmes and retained the same main pattern: network architecture and clinical outcomes were visible in all clusters, whereas registration and cybersecurity were visible in one cluster each. Urological telesurgery has entered early comparative evaluation, including one randomised trial, but public implementation reporting remains uneven. The clearest residual visibility gaps in full-length records concern registration and cybersecurity; short public records are additionally constrained by format. A concise implementation-reporting box or supplement could improve reproducibility and external appraisal without implying that non-reporting equals poor clinical conduct.

Indexed as

Medical AuditRobotic Surgical ProceduresUrologic Surgical ProceduresHumansRandomized Controlled Trials as TopicIDEAL frameworkImplementation sciencePRISMA-ScRRemote robotic surgeryRobotic surgeryTelesurgeryUrology

Identifiers

PMID42303805
PMCPMC13272602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.